Surrogate endpoint biomarkers for human colon carcinogenesis

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 415-420

  Dolara, Piero ^a   Caderni, Giovanna ^a   Luceri, Cristina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

ACF; Cell proliferation; Colon cancer

Indexed keywords

BIOCHEMICAL MARKER;

APOPTOSIS; CARCINOGENESIS; COLON CANCER; COLON MUCOSA; CONFERENCE PAPER; CRYPT CELL; ENDOSCOPY; ETHNIC DIFFERENCE; EUROPE; GENE MUTATION; HISTOLOGY; HUMAN; JAPAN; NORTH AMERICA; POLYP; PRIORITY JOURNAL; RECURRENCE RISK;

ANIMALS; APOPTOSIS; CELL DIVISION; CHORISTOMA; COLONIC NEOPLASMS; DIET; EUROPE; GENETICS, POPULATION; HUMANS; JAPAN; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 17444443145     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00215-5     Document Type: Conference Paper

References (33)

1. Augenlicht L.H., Richards C., Corner G., Pretlow T.P. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene. 12:1996;1767-1772.
2. Bapat B., Noorani H., Cohen Z., Berk T., Mitri A., Gallie B., Pritkker K., Gallinger S., Detsky A.S. Cost comparison of predictive testing versus conventional clinical screening for familial adenomatous polyposis. Gut. 44:1999;698-703.
3. Bird R.P., Medline A., Furrer R., Bruce W.R. Toxicity of orally administered fat to the colonic epithelium of mice. Carcinogenesis. 6:1985;1063-1066.
4. Bradley B.A., Evers B.M. Molecular advances in the etiology and treatment of colorectal cancer. Surg. Oncol. 6:1997;143-156.
5. Caderni G., Stuart E., Anderson A.M., Bruce W.R. A CHO cell line resistent to deoxycholic acid. Cancer Lett. 38:1987;119-127.
6. Caderni G., Bianchini F., Dolara P., Kriebel D. Proliferative activity in the colon of the mouse and its modulation by dietary starch, fat and cellulose. Cancer Res. 49:1989;1655-1659.
7. Caderni G., Bianchini F., Mancina A., Spagnesi M.T., Dolara P. Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine. Cancer Res. 51:1991;3721-3725.
8. Caderni G., Lancioni L., Palli D., Saieva C., Trallori G., Manneschi L., Renai F., Marcoccia M., Russo A., Dolara P. A dietary trial with a short-term low-sucrose diet in an Italian population: effects on colorectal mucosal proliferation. Nutr. Cancer. 32:1998;159-164.
9. Choug L.C., Chapkin R.S., Lupton J.R. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis. 4:1997;721-730.
10. Deschener E.E., Lipkin M. Proliferative patterns in colonic mucosa in familial polyposis. Cancer. 35:1975;413-418.
11. Dolara P., Caderni G., Lancioni L., Giannini A., Anastasi A., Fazi M., Castiglione G. Aberrant crypt foci in human colon carcinogenesis. Cancer Detect. Prev. 21:1997;135-140.
12. Greenberg E.R., Baron J.A., Tosteson T.D. et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study. New Engl. J. Med. 21:1994;141-147.
13. Grundfest S.F., Fazio V., Weiss R.A., Jagelman D., Lavery I., Weakley F.L., Turnbull R.B. Jr The risk of cancer following colectomy and ileorectal anastomosis for extensive mucosal ulcerative colitis. Ann. Surg. 193:1981;9-14.
14. Heinen C.D., Shivapurkar N., Tang Z., Groden J., Alabaster O. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 56:1996;5339-5341.
15. Hoff G., Sauar J., Vatn M.H. et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years follow-up of the Telemark Polyp Study I. A prospective, controlled population study. J. Gastroenterol. 31:1996;1006-1010.
16. Jacobs L.R., Lupton J.R. Relationship between colonic luminal pH, cell, proliferation, and colon carcinogenesis in 1,2-dimethylhydrazine treated rats fed high fiber diets. Cancer Res. 46:1986;1727-1734.
17. Jen J., Powell S.M., Papadopoulos N., Smith K.J., Hamilton S.R., Vogelstein B., Kinzler K.W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54:1994;5523-5526.
18. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
19. Lipkin M., Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. New Engl. J. Med. 313:1985;1381-1384.
20. MacLennan R., Macrae F., Bain C. et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J. Natl. Cancer Inst. 87:1995;1760-1766.
21. Miller E.C., Miller J.A. Carcinogens and mutagens that may occur in foods. Cancer. 58:1986;1795-1803.
22. Modica S., Roncucci L., Benatti P., Gafà L., Tamassia M.G., Dardanoni L., Ponz De Leon M. Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-years experience of 2 population based colorectal cancer registries. Int. J. Cancer. 62:1995;685-690.
23. Parkin D.M., Muir C.S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci. Publ. 120:1992;45-173.
24. Pretlow T.P., Brasitus T.A., Fulton N.C., Cheyer C., Kaplan E.L. K-ras mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85:1993;2004-2007.
25. Risio M., Lipkin M., Newmark H., Yang K., Rossini F.P., Steele V.E., Boone C.W., Kelloff G.J. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res. 56:1996;4910-4916.
26. Rozen P., Fireman Z., Fine N., Wax Y., Ron E. Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. Gut. 30:1989;650-655.
27. Samaha H.S., Kelloff G.J., Steele V., Rao C.V., Reddy B.S. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res. 57:1997;1301-1305.
28. Schatzkin A., Lanza E., Freedman L.S. et al. The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol. Biomarkers Prev. 5:1996;375-383.
29. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. New Engl. J. Med. 339:1998;1277-1284.
30. Tomecki R., Gogulski A., Cwikla M. et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years follow-up of the Telemark Polyp Study I. A prospective, controlled population study. J. Gastroenterol. 31:1996;1006-1010.
31. Tonelli F., Dolara P., Batignani G., Monaci J., Caderni G., Spagnesi M.T., Luceri C., Amorosi A. Effects of short chain fatty acids on mucosal proliferation and inflammation of ileal pouches in patients with ulcerative colitis and familial polyposis. Dis. Colon Rectum. 38:1995;974-978.
32. Wargovich M.J., Eng V.W., Newmark H.L. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 23:1984;253-258.
33. Yamashita N., Minamoto T., Ochiai A., Onda M., Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer. 75:1995;1527-1533.